Show menu

News

image
SEQENS announces the appointement of a new CEO
France-based SEQENS, a leader in the development and production of active pharmaceutical ingredients, pharmaceutical intermediates, and specialty ingredients, announces that Pascal Villemagne has been named Chief Executive Officer, effective 1st April 2025. Pascal brings a wealth of experience to the role, having previously served as CEO of CARBOGEN AMCIS, a company specializing in the manufacture … Continued
Read more
Glycuron Marshmallow KV without logo
SEQENS Personal Care new article “Marshmallow Root: Botanical ingredient for hair protection and reparation against environmental stress”
Read more
image
BBG Advanced Therapies and CELLforCURE partner to provide transatlantic manufacturing solutions for ATMPs
Read more
Key Visual SEQENS Personal Care Webinar
SEQENS Personal Care at InCosmetics Asia, come and meet us !
Read more
Key visual_Celebr'Age Getto_SEQENS Personal Care
SEQENS Personal Care new article “How to improve skin well-being by taking inspiration from centenarians’ longevity secrets
Read more
image
CELLforCURE by SEQENS to Manufacture Galapagos’ CAR T-Cell Therapy Candidates for Upcoming Trials
Read more
Key Visual SEQENS Personal Care Webinar
SEQENS Personal Care WEBINAR
Read more
image
CellProthera Selects CELLforCURE by SEQENS for Phase 3 GMP Manufacturing
Read more
SEQENS Personal care Sens'FlowerTM Key visual
SEQENS Personal Care article “From field to product: floral innovations”
Read more
SEQENS Personal Care Glycuron 2.78 Key Visual
SEQENS Personal Care article_The sugar paradox: skin’s friends and foes
Read more
image
Pascal Villemagne is SEQENS new CEO 
Read more
image
SEQENS and Novonesis announce strategic partnership for enhancing customer’s access to industrial biocatalytic processes
Read more
image
SEQENS and APPLEXION announce strategic partnership for the distribution of SEQENZYM FT
Read more
1 2 3 7